Abstract Natural killer (NK)/T-cell lymphomas are aggressive malignancies with a
predilection for Asian and South American populations. Epstein–Barr virus (EBV) infection in …

Extranodal natural killer (NK)/T-cell lymphoma is an aggressive malignancy of putative NK-
cell origin, with a minority deriving from the T-cell lineage. Pathologically, the malignancy …

Natural killer/T cell lymphoma (NKTCL) is an aggressive and heterogeneous entity of non-
Hodgkin lymphoma, strongly associated with Epstein-Barr virus (EBV) infection. To identify …

Abstract The World Health Organization classification of lymphoid neoplasms updated in
2008 represents a worldwide consensus on the diagnosis of these tumors and is based on …

Natural killer/T-cell lymphoma (NKTCL) is a malignant proliferation of CD56+ and cytoCD3+
lymphocytes with aggressive clinical course, which is prevalent in Asian and South …

Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms
with generally poor clinical outcome. Currently 50% of PTCL cases are not classifiable …

Muscle-invasive bladder carcinoma (MIBC) constitutes a heterogeneous group of tumors
with a poor outcome. Molecular stratification of MIBC may identify clinically relevant tumor …

Abstract Natural killer (NK)/T-cell lymphomas and NK-cell leukemias are aggressive
malignancies. Occurring worldwide, they show a predilection for Asian and South American …

Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive
diseases associated with poor outcome. Studies that focus specifically on PTCL are …

Serine proteases form a large family of protein-cleaving enzymes that play an essential role
in processes like blood coagulation, apoptosis and inflammation. Immune cells express a …